How Elan's $1B Buyback Shakes Up Looming Hostile Bid
Elan Corp. closed a $1 billion stock buyback Thursday without a single mention of a looming $7.3 billion hostile takeover offer from Royalty Pharma. But the move promises to shake up...To view the full article, register now.
Already a subscriber? Click here to view full article